Zn²⁺-Triggered Drug Release from Biocompatible Zirconium MOFs Equipped with Supramolecular Gates

Medicine and Dentistry

• Zinc Ion 100%
• Drug Delivery System 50%
• Controlled Release 50%
• Biodegradability 50%
• Prematurity 50%
• Synaptic Vesicle 50%
• Polycyclic Aromatic Hydrocarbon 50%
• Drug Carrier 50%
• Controlled Drug Release 50%
• Therapeutic Agent 50%
• Central Nervous System Disease 50%

Chemical Engineering

• Metal-Organic Frameworks 100%
• Auxiliaries 50%
• Polycyclic Aromatic Hydrocarbon 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Zinc Ion 100%
• Central Nervous System Disease 50%
• Prematurity 50%